Ohsumi, Shozo http://orcid.org/0000-0002-5989-1763
Nishimura, Reiki
Masuda, Norikazu
Akashi-Tanaka, Sadako
Suemasu, Kimito
Yamauchi, Hideko
Tokunaga, Eriko
Ikeda, Tadashi
Nishi, Tsunehiro
Hayashi, Hiroto
Iino, Yuichi
Takatsuka, Yuichi
Ohashi, Yasuo
Inaji, Hideo
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (a Grant-in-Aid for research of cancer treatment from the Ministry of Health, Labour, Welfare of Japan, No. 13-9, No. 21-7-4)
Article History
Received: 9 May 2022
Accepted: 18 September 2022
First Online: 30 September 2022
Declarations
:
: Ohsumi S.: fees for non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus); AstraZeneca. Nishimura R.: none. Masuda N.: Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus); Chugai, AstraZeneca, Pfizer, Eli-Lilly, Eisai, Takeda. Contracted Research; Chugai, AstraZeneca, Kyowa-Kirin, MSD, Novartis, Pfizer, EliLilly, Eisai, DaiichiSankyo. Akashi-Tanaka S.: fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus); AstraZeneca. Suemasu K.: none. Yamauchi H.: contracted Research; AstraZeneca. Tokunaga E.: fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus); AstraZeneca. Ikeda T.: none. Nishi T.: none. Hayashi H.: none. Iino Y<b>.</b>: none. Takatsuka Y.: none. Ohashi Y.<b>:</b> none, Inaji H.: none.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was received from all individual participants included in the study.
: Authors are responsible for correctness of the statements provided in the manuscript. All individual participants agreed on the data being published in an academic article.